How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Close this folder3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
View the documentDeveloping locally relevant introductory information
Open this folder and view contentsGeneral entries at the front of a national formulary
Close this folderAdditional information at the front of the national formulary
View the documentInstructions on how to use the formulary
View the documentGlossary
View the documentPolicies and procedures of the national formulary and national formulary committee
View the documentNational policies and regulations
View the documentList of changes
View the documentAdapting the “General advice to prescribers” section of the WHO model formulary
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

National policies and regulations

The following items can be included as separate sections, or some of them may be adapted from the “General advice to prescribers” section of the WMF:

- guidelines for prescribers on national requirements on prescription writing, prescribing dangerous or controlled preparations, principles of rational drug use, prescribing for patients with special needs (children, the elderly, pregnant and lactating women, those with renal and hepatic disease, and those requiring intensive and palliative care);

- guidelines on good dispensing practices including checking prescriptions, accuracy of dispensing, labelling, packaging and patient counselling;

- reporting of adverse drug reactions; and

- reporting of defective medicines or counterfeit products.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014